Opthea Limited (OPT)
NASDAQ: OPT · IEX Real-Time Price · USD
2.120
+0.050 (2.42%)
At close: Jul 19, 2024, 4:00 PM
2.170
+0.050 (2.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Opthea Market Cap
Opthea has a market cap or net worth of $305.22 million as of July 22, 2024. Its market cap has increased by 135.87% in one year.
Market Cap
305.22M
Enterprise Value
302.99M
1-Year Change
135.87%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since the IPO on October 16, 2020, Opthea's market cap has decreased from $582.45M to $305.22M, a decrease of -47.60%. That is a compound annual growth rate of -15.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 123.80M | -28.15% |
| Dec 29, 2023 | 172.30M | -26.96% |
| Dec 30, 2022 | 235.90M | -28.73% |
| Dec 31, 2021 | 331.00M | -31.27% |
| Dec 31, 2020 | 481.60M | -17.32% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OraSure Technologies | 310.63M |
| MacroGenics | 308.16M |
| Sutro Biopharma | 307.96M |
| Pulmonx | 307.42M |
| Jasper Therapeutics | 305.33M |
| Enanta Pharmaceuticals | 303.29M |
| Atea Pharmaceuticals | 300.68M |
| SOPHiA GENETICS | 299.42M |